▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Olivia Zitkus

XMFoliviaz

@omzitkus

Recent Articles by Olivia Zitkus

GettyImages-1222248088

Jan 29, 2021 by Olivia Zitkus

Here's How the Genetic Testing Industry Can Get Even Bigger

Genetic testing companies have to appeal to several stakeholders in the healthcare system in order to make it to the next level.

GettyImages-1250234582

Dec 30, 2020 by Olivia Zitkus

Here's What A Doctor Thinks Are The Biggest Vaccination Challenges

Vaccination logistics can make vaccine development look easy.

GettyImages-1222894162

Dec 30, 2020 by Olivia Zitkus

Beyond Pfizer and Moderna: What Investors Need to Know About the Next COVID Vaccines in The Pipeline

Now that two coronavirus vaccines have been authorized for use, it's a serious question whether people will be willing to participate in other clinical trials months down the road.

GettyImages-1213501739

Dec 29, 2020 by Olivia Zitkus

COVID Vaccine Stocks: The Hares Have Won, But Watch the Tortoises

They were first to cross the finish line, but that doesn't mean their coronavirus vaccines will be the best.

GettyImages-1279787727

Dec 29, 2020 by Olivia Zitkus

Ask A Doctor: Here's How The U.S. Can Reach Herd Immunity

It'll be all about vaccine supply over the next several months.

GettyImages-1266494637

Dec 28, 2020 by Olivia Zitkus

What Should Investors Know About FDA Decisions On COVID Vaccines?

Investors can learn new and actionable information about coronavirus vaccines through public FDA advisory committee meetings.

GettyImages-1264981672

Dec 28, 2020 by Olivia Zitkus

Ask A Doctor: What Does The Post-Pandemic World Look Like?

The end of the coronavirus pandemic is coming into view. But some new practices, processes, and innovations might not be going anywhere, even after herd immunity is reached.

GettyImages-1288813054

Dec 28, 2020 by Olivia Zitkus

A Vaccination Expert On What Investors Need To Know About COVID Vaccines Now

Even though two vaccines have been authorized, investors in the coronavirus vaccine race shouldn't rest just yet.

GettyImages-1251663430

Dec 27, 2020 by Olivia Zitkus

A Public Health Expert on the Coronavirus Vaccine: Who Should Be Immunized Next?

Over one million Americans have already received their first coronavirus vaccine dose. There are 327 million to go.

GettyImages-1281663349

Dec 27, 2020 by Olivia Zitkus

You're Going to Want to Hear This Doctor's Advice on Buying COVID Vaccine Stocks

Two coronavirus vaccines have already received Emergency Use Authorization in the U.S., but the true winner might not be who you think.

GettyImages-1285653618

Dec 26, 2020 by Olivia Zitkus

Vaccination Expert: What Investors Should Watch In 2021

Coronavirus vaccines are here (in record time). But there's still a lot we have to learn about them.

GettyImages-1222894162

Dec 26, 2020 by Olivia Zitkus

Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold?

Its use in a coronavirus vaccine is an exciting step forward, but mRNA technology is unlikely to solve all of our problems.

GettyImages-1250234582

Dec 25, 2020 by Olivia Zitkus

What Should Investors Know About 2-Dose COVID Vaccines?

A vaccination expert unpacks the challenges presented by a two-dose schedule.

GettyImages-1251663430

Dec 25, 2020 by Olivia Zitkus

What We Still Don't Know About COVID Vaccines (And How We'll Get Answers)

It'll take more time and new studies in order to know how well the new vaccines are slowing the spread.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services